$14.96
0.493.39%
At Close: -
$14.96
00.00%
After Hours: Aug 23, 4:00 PM EDT
15 minutes delayed
4D Molecular Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of 4D Molecular Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.63 | $-0.71 | 11.3 % |
Mar 2024 | 2024-05-09 | $-0.66 | $-0.74 | 10.8 % |
Dec 2023 | 2024-02-29 | $-0.77 | $-0.74 | -4.05 % |
Sep 2023 | 2023-11-09 | $-0.24 | $-0.54 | 55.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $28.00K | $780.00K | -96.4 % |
Dec 2023 | 2024-02-29 | $-17.00K | $2.06M | -100.8 % |
Sep 2023 | 2023-11-09 | $20.20M | $9.87M | 104.7 % |
Jun 2023 | 2023-08-09 | $239.00K | $850.00K | -71.9 % |
4D Molecular Therapeutics (FDMT) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.63, which beat the estimate of $-0.71.
The Actual Revenue was $5K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.